US Patent Issued to BeOne Medicines | on March 31 for "Imidazo[2,1-f[1,2,4triazin-4-amine as TLR8 agonists" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,096, issued on March 31, was assigned to BeOne Medicines | GmbH (Basel, Switzerland).

"Imidazo[2,1-f[1,2,4triazin-4-amine as TLR8 agonists" was invented by Guoliang Zhang (Beijing), Jianzhuang Miao (Beijing) and Ce Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are an imidazo[2,1-f][1,2,4]triazin-4-amine derivative used as a TLR8 agonist or a stereoisomer thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing same. Further disclosed is a method for treating cancers using the imidazo[2,1-f][1,2,4]triazin-4-amine derivative or the stereoisomer thereof or the pharmaceutically acceptab...